Home > Insider Trading > Filing (0001209191-17-045979)

Filing Details

Accession Number:: 0001209191-17-045979
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-07-21 16:43:32
Reporting Period:: 2017-07-19

Filing Date:: 2017-07-21
Accepted Time:: 2017-07-21 16:43:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1539029	Clearside Biomedical Inc.	CLSD	Pharmaceutical Preparations (2834)	452437375

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1664697	H. Daniel White	C/O Clearside Biomedical, Inc. 900 North Point Parkway, Suite 200 Alpharetta GA 30005	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-07-19	3,600	$9.79	499,967	No	4	S	Direct
Common Stock	Disposition	2017-07-20	3,600	$9.71	496,367	No	4	S	Direct
Common Stock	Disposition	2017-07-19	400	$9.79	38,109	No	4	S	Indirect	By White Family Trust
Common Stock	Disposition	2017-07-20	400	$9.71	37,709	No	4	S	Indirect	By White Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	By White Family Trust
No	4	S	Indirect	By White Family Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	301	Indirect	As UTMA custodian for son
Common Stock	844	Indirect	As UTMA custodian for son
Common Stock	1,188	Indirect	As UTMA custodian for son

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the record holders of the securities on March 16, 2017.
This transaction was executed in multiple trades at prices ranging from $9.58 to $10.08, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $9.60 to $9.98, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
These securities are held in trust for the benefit of the reporting person's children. The reporting person's wife serves as trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
These securities are held for the benefit of the reporting person's son under the Georgia Uniform Transfers to Minors Act, for which the reporting person serves as custodian. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.